vitamin k5 has been researched along with cyclin d1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, T; Deguchi, A; Hitomi, M; Kuriyama, S; Masaki, T; Mitoro, A; Nakai, S; Nonomura, T; Ogawa, M; Tsujimoto, T; Uchida, N; Yoshiji, H | 1 |
1 other study(ies) available for vitamin k5 and cyclin d1
| Article | Year |
|---|---|
Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p16; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; L-Lactate Dehydrogenase; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vitamin K; Vitamin K 2; Vitamin K 3; Xenograft Model Antitumor Assays | 2005 |